Estimated and measured donor creatinine clearance are poor predictors of long-term renal graft function and survival

American Journal of Transplantation

Volumn 2, Issue 4, 2002, Pages 373-380

  Pokorná, Eva ^a   Schück, Otto ^a   Vítko, Stefan ^a   Ekberg, Henrik ^b  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Creatinine clearance; Donor renal function; Kidney transplantation

Indexed keywords

AZATHIOPRINE; CREATININE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; OKT 3; STEROID; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CREATININE CLEARANCE; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORGAN TRANSPLANTATION; PROGNOSIS; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; AGE FACTORS; AGING; CREATININE; FEMALE; GRAFT SURVIVAL; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TIME FACTORS; TISSUE DONORS;

EID: 0036556209     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-6143.2002.20414.x     Document Type: Article

References (26)

1. Alexander JW, Vaughn WK. The use of 'marginal' donors for organ transplantation. The influence of donor age on outcome. Transplantation 1991; 51: 135-141.
2. Feduska NJ Jr. Cecka JM. Donor factors. Clin Transpl 1994; 381-394.
3. Cantarovich D, Giral-Classe M, Le Sant JN et al. Renal transplantation from cadaver donors over 60 years old. Clin Transpl 1994; 237-242.
4. Nghiem DD, Hsia S, Carpenter BJ et al. Renal transplantation at Allegheny General Hospital with special reference to the use of extremeage cadaveric donors. Clin Transpl 1994; 213-218.
5. Taylor RJ, Engelsgjerd JS. Contemporary criteria for cadaveric organ donation in renal transplantation: the need for better selection parameters. World J Urol 1996; 14: 225-229.
6. Vianello A, Mastrosimone S, Calconi G et al. Influence of donor age on cadaver kidney graft function and survival: univariate and multivariate analyses. Nephron 1993; 65: 541-548.
7. Kumar MS, Panigrahi D, Dezii CM et al. Long-term function and survival of elderly donor kidneys transplanted into young adults. Transplantation 1998: 65: 282-285.
8. Rao KV, Kasiske BL, Odlund MD, Ney AL, Andersen RC. Influence of cadaver donor age on posttransplant renal function and graft outcome. Transplantation 1990; 49: 91-95.
9. Rowe JW, Andres R, Tobin JD, Norris AH, Shock NW. The effect of age on creatinine clearance in men: a cross-sectional and longitudinal study. J Gerontol 1976; 31: 155-163.
10. Nyengaard JR, Bendtsen TF. Glomerular number and size in relation to age, kidney weight, and body surface in normal man. Anat Rec 1992; 232: 194-201.
11. Andres A, Morales JM, Herrero JC et al. Double versus single renal allografts from aged donors. Transplantation 2000; 69: 2060-2066.
12. Alfrey EJ, Lee CM, Scandling JD, Pavlakis M, Markezich AJ, Dafoe DC. When should expanded criteria donor kidneys be used for single versus dual kidney transplants? Transplantation 1997; 64: 1142-1146.
13. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
14. Gault MH, Longerich LL, Harnett JD, Wesolowski C. Predicting glomerular function from adjusted serum creatinine. Nephron 1992; 62: 249-256.
15. Thomas DM, Coles GA, Williams JD. What does the renal reserve mean? Kidney Int 1994; 45: 411-416.
16. ter Wee PM, Tegzess AM, Donker AJ. Pair-tested renal reserve filtration capacity in kidney recipients and their donors. J Am Soc Nephrol 1994; 4: 1798-1808.
17. Wheeler DC, Cosgriff PS, Bennett SE, Walls J. Measurement of renal functional reserve of the single kidney in man. Clin Nephrol 1987; 28: 87-92.
18. Wilson RF, Soullier G. The validity of two-hour creatinine clearance studies in critically ill patients. Crit Care Med 1980; 8: 281-284.
19. Martin C, Alaya M, Bras J, Saux P, Gouin F. Assessment of creatinine clearance in intensive care patients, Crit Care Med 1990; 18: 1224-1226.
20. Ekberg H, Bäckman L, Tufveson G, Tydén G, Nashan B, Vincenti F. Daclizumab prevents acute rejection and improves patient survival post transplantation: 1 year pooled analysis. Transpl Int 2001; 13: 151-159.
21. Vincenti F, Ramos E, Brattström C et al. Multicenter trial exploring calcineurin inhibitor avoidance in renal transplantation. Transplantation 2001; 71: 1282-1287.
22. Halloran PF, Melk A, Barth C. Rethinking chronic allograft nephropathy: the concept of accelerated senescence. J Am Soc Nephrol 1999; 10: 167-181.
23. Lu AD, Carter JT, Weinstein RJ et al. Outcome in recipients of dual kidney transplants: an analysis of the dual registry patients. Transplantation 2001; 69: 281-285.
24. Johnson LB, Kuo PC, Schweitzer EJ et al. Double renal allografts successfully increase utilization of kidneys from older donors within a single organ procurement organization. Transplantation 1996; 62: 1581-1583.
25. Carter JT, Lee CM, Weinstein RJ, Lu AD, Dafoe DC, Alfrey EJ. Evaluation of the older cadaveric kidney donor: the impact of donor hypertension and creatinine clearance on graft performance and survival. Transplantation 2001; 70: 765-771.
26. Pokorna E, Vitko S, Chadimova M, Schuck O, Ekberg H. Proportion of glomerulosclerosis in procurement wedge renal biopsy cannot alone discriminate for acceptance of marginal donors. Transplantation 2000; 69: 36-43.